Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-20

FDA Approved: OZEMPIC — Original Application (Novo Nordisk)

View source ↗

Summary

FDA approval of the original application for OZEMPIC's oral semaglutide formulation by Novo Nordisk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OZEMPIC (semaglutide)

Snippet

ORIG AP for OZEMPIC (ORAL SEMAGLUTIDE)